Purpose The pharmacology, pharmacokinetics, efficacy, and safety of apixaban are reviewed. Summary Apixaban is an oral, direct, selective factor Xa inhibitor with a rapid onset of action. It has a ...

Three new oral anticoagulants (dabigatran, rivaroxaban and apixaban) have been recently approved across the world for stroke prevention in AF. Despite their efficacy; their usage in CKD patients ...

Atrial fibrillation emerged as a frequent and potentially prognostic complication in wild-type transthyretin amyloidosis, ...

Investigators studied apixaban pharmacokinetics, pharmacodynamics, and hemorrhage risk by kidney function. Kidney function is a major predictor of hemorrhage among patients with atrial fibrillation ...

Non-valvular atrial fibrillation accounts for 13–26% of acute ischaemic strokes.1 Direct oral anticoagulants (DOACs) are ...

In-hospital, all-cause mortality among critically ill patients with AF is associated with the Endothelial Activation and Stress Index.

Medicare has two coverage options for medications like Eliquis: Part D and Medicare Advantage. Learn which may best meet your needs.

Targeted ablation guided by voltage mapping improved rhythm outcomes in individuals with recurrent atrial fibrillation after ...

The service moved up the retirement of the final 162 close attack fighters by two years in a budget request and asked for far ...

Outcomes in the observational study were better among patients treated by surgeons who regularly do ablations.